Lifco Q3 2024: Sales in line, slight margin softness - Redeye

Redeye provides its initial take on Lifco’s Q3 2024 report, which broadly aligned with our estimates. We judge that positives from the report include sales aligning with our estimates and solid growth for business areas Dental and Systems Solutions. Notable negatives include a slightly softer-than-expected EBITA margin and continued weakness in business area Demolition & Tools.

Länk till analysen i sin helhet: https://www.redeye.se/research/1045041/lifco-q3-2024-sales-in-line-slight-margin-softness?utm_source=finwire&utm_medium=RSS